Resources

For the latest in nextgen biomed, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox

Immunotherapy (Non-Oncology)

ChemPartner: Inflammation and Immunology

Specialize in primary immune cells with a full panel of assay format (in vitro and ex vivo) on cells from different species, providing multiple optional readouts.
Immuno-Oncology

ChemPartner: Nuclear Hormone Receptor Screening

Overview of Capabilities.
Immuno-Oncology

ChemPartner: Tailored Drug Discovery & Development

ChemPartner has the capabilities and expertise to support the end to end drug discovery process across multiple modalities (illustrated below with the small molecule flow scheme). We support the process with expertise and resources at every stage in a fully managed and integrated manner.
Immuno-Oncology

Crown Bioscience: Discover the Infinite Power of Partnership

We are Crown Bioscience and this is where Innovation and Quality Transforms Scientific Discovery
Drug Discovery & Development

GD2 CAR-T cells engineered using retroviral transduction or CRISPR editing exhibit strong cytolytic potency against glioma stem cells

Axion BioSystems’ Maestro Z platform offers impedance-based cell analysis for real-time, label-free monitoring of cell viability, morphology, cytolysis, and signaling.
Antibody & Protein Engineering

Tiny but Mighty Molecular Syringe Developed Using AI

An AI-modified molecular “syringe” harnessed from bacteria could revolutionise protein delivery for gene and cancer therapies.
Biomarkers & Precision Medicine

Volition: Nu.Q Discover

An innovative solution to profiling nucleosomes.
Manufacturing & Bioprocessing

Metabolic Modelling and Machine Learning Technologies in Cell and Gene Manufacturing

Integrating PAT into metabolic modelling can help optimise the product obtained from cell cultures, augmenting the manufacturing process.

In Vivo Model Design and Assay Selection to Aid in Progression from Preclinical to Clinical

Nexelis discussed the preclinical stage of vaccine development at Vaccines EU 2022, highlighting that the choices made during this stage will impact the rest of the development process.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery